Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010
Date:2/1/2011

cted procedural volumes; new product approvals, launches and sales; regulatory compliance; our market position; cash flow; write-down of goodwill and other asset impairments; our capacity to fund acquisitions and other investments and to successfully complete acquisitions and integrate them into our business; our ability to successfully separate our Neurovascular business; our ability to reduce our debt obligations; and our restructuring activities.
If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.
These risks and uncertainties, in some cases, have affected and in the future could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.
As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Risks and uncertainties that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions and the market acceptance of those products; clinical trial results; demographic trends; intellectual property; litigation; financial market conditions; the effect of our goodwill impairment charges and our restructuring initiatives; closing of announced acquisitions and integration of acquired companies; and future business decisions made by us and our competitors. New risks and uncertainties may arise from time to time and are difficult to predict. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.
For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item IA - 
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System
2. Boston Scientific Responds to DOJ Civil Lawsuit
3. Boston Scientific Announces First Use of Blazer® Open-Irrigated Catheter in U.S.
4. Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent
5. Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent
6. Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan
7. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2010 Financial Results
8. Boston Scientific to Acquire Atritech
9. Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease
10. Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article
11. Boston Scientific Completes Acquisition of Sadra Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ("Galmed"), ... commercialization of a once-daily, oral therapy for the treatment ... it will host a conference call and webcast on ... period ended March 31, 2015 and to provide an ... program for aramchol. Conference Call & ...
(Date:5/6/2015)... GERMANTOWN, Md. , May 6, 2015 ... neural stem cell technology to develop small molecule and ... the appointment of Jonathan Lloyd Jones to ... th . Mr. Lloyd Jones ... of corporate finance and business development experience.   Most recently, ...
(Date:5/6/2015)... 6, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ... for the three-month period ended March 31, 2015. First quarter ... million, an increase of 19% as compared to $7.0 ... Product revenues increased 41% year-over-year, enabled by the return ... Merck Serono in the fourth quarter of 2014; ...
Breaking Medicine Technology:Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 2Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 5Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 6Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 7Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 8Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 9Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 10Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 11
... 26, 2007,/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. , ... announced that,the two-year data from its European ... ("Vascular Wrap(TM)"),will be presented today at a ... the safety and efficacy of the Vascular,Wrap(TM) ...
... cord and other central,nervous system transplants possible, BOSTON, ... Eye Research Institute, an affiliate of Harvard Medical,School, ... into the adult central nervous system. The,study found ... induced by,stem cells) has the ability to break ...
Cached Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 2Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 3
(Date:5/6/2015)... Chinese technology company, Elink-IOT, has launched ... raise AUD$150,000 to finalize development of Watcher, the world’s ... watch designed to help the owner keep track of ... the item is out of range. , Using ... wearer and sends alerts on its E-paper display, and ...
(Date:5/6/2015)... The future of nursing is influenced by ... an increase in educational requirements. Leslie Brown, branch manager ... insight on these trends and how a travel nurse ... that exist in the nursing field. , Technology ... has been prevalent across the U.S. ever since the HITECH ...
(Date:5/6/2015)... York, NY (PRWEB) May 06, 2015 ... producer in New York City, announced today that it ... Creative Awards for a presentation video produced on behalf ... award in the category of motion graphics. , The ... Professionals (AMCP), received over 6000 entries from 22 countries. ...
(Date:5/6/2015)... 2015 “ Radiation Island ” was featured ... a look at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... graphic games on iOS. , Touted as one of the ... loved by users, which is obvious because of its rating ...
(Date:5/5/2015)... 06, 2015 Social Media Regulatory Affairs ... Media Your Most Powerful Marketing Tool and Get the ... http://www.fdanews.com/SocialMedia , Social media … Is it ... media’s reach. Patients are using it — learning about ... what they’ve discovered. , But, it can become a ...
Breaking Medicine News(10 mins):Health News:Crowdfunding campaign Launched for World’s First Anti-Loss Smart Watch 2Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 2Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 3Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 4Health News:The SGNY Group Wins Platinum Hermes Creative Award 2Health News:Top Grossing iPhone Game, Radiation Island, Was Featured on NewsWatch 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 3Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 4
... , KAYUNGA, Uganda, July 10 Uganda was the first ... national prevalence in HIV. The epidemic, however, remains serious as ... field have begun promoting a low cost and powerful weapon ... , Three trials in Kenya, Uganda and South Africa have ...
... Inc., the parent company of Ruth,s Chris Steak House, announced ... Street Ruth,s Chris Steak House to Tulane University for the ... a neighborhood-based medical home that will provide care to patients ... The building will honor the restaurant company,s founder, Ruth ...
... Newswise -- President Obama today announced that two Fred ... nation,s highest honor for scientists at the beginning of ... Ph.D., and cancer-prevention researcher Ulrike "Riki" Peters, Ph.D., are ... Early Career Award for Scientists and Engineers (PECASE). Each ...
... 10 Looking to reinforce its positioning as the city,s pre-eminent ... advertising campaign that speaks to New Yorkers as only a born ... "Your city. Your drugstore. Duane Reade", the campaign will ... as well as on phone kiosks, billboards and urban panels near ...
... , ... J-1/H-1B foreign physician immigration conference and job fair series announced by Pederson Immigration Law ... ... announced the details today for the 2009 J-1/H-1B Foreign Physician Immigration Conference and Job ...
... Earvin "Magic" Johnson, Chairman and Founder of the Magic ... Michaels Scholarship Program Life Skills Leadership Conference in Los ... scholarship students attending. They come from all around the ... entertain and empower. The Taylor Michaels Scholarship Program (TMSP) ...
Cached Medicine News:Health News:Ugandan Medical Male Circumcision Program Launched to Prevent HIV Transmission 2Health News:Ruth's Hospitality Group Inc. donates Broad Street building to Tulane 2Health News:Ruth's Hospitality Group Inc. donates Broad Street building to Tulane 3Health News:Two Fred Hutchinson Cancer Research Center Scientists Receive Presidential Early Career Award 2Health News:Two Fred Hutchinson Cancer Research Center Scientists Receive Presidential Early Career Award 3Health News:Two Fred Hutchinson Cancer Research Center Scientists Receive Presidential Early Career Award 4Health News:Two Fred Hutchinson Cancer Research Center Scientists Receive Presidential Early Career Award 5Health News:Duane Reade Dispenses a Large Dose of Marketing, as it Strengthens its Hometown Connection 2Health News:Duane Reade Dispenses a Large Dose of Marketing, as it Strengthens its Hometown Connection 3Health News:Pederson Immigration Law Group Announces 14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series 2Health News:Earvin 'Magic' Johnson and the Magic Johnson Foundation Give Students their 'Blueprint for Success' at Annual Leadership Conference 2
20 foot distance 22-1/2" X 11-1/2". This test for illiterate patients has HOTV letters on one side and Allen figures on the other....
McIntyre-binkhorst irrigating cannula....
Binkhorst, length 35 mm....
Army navy retractor set....
Medicine Products: